Showing 1171-1180 of 3380 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20533/Therapeutics Update
https://practicaldermatology.com/topics/skin-cancer-photoprotection/theraputics-update/20492/New products and pharmacologic developmentsA History of Phlebology: Warts and All, Part 3
https://practicaldermatology.com/topics/practice-management/a-history-of-phlebology-warts-and-all-part-3/20843/Monoclonal Antibodies for Restoring a Healthy Skin Microbiome in Atopic Dermatitis Patients
https://practicaldermatology.com/topics/research-update/monoclonal-antibodies-restoring-healthy-skin-microbiome-atopic-dermatitis-patients/24566/Monoclonal Antibodies for Restoring a Healthy Skin Microbiome in Atopic Dermatitis PatientsRecent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-44/23875/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-18/23367/Attention, Please! Why Dermatologists Need to Confront Burnout
https://practicaldermatology.com/topics/practice-management/attention-please-why-dermatologists-need-to-confront-burnout/20557/Raising awareness of the problem is essential to finding a solution.DermWireTV: Incyte's Opzelura, BMS Patient Week, Science of Skincare Summit
https://practicaldermatology.com/topics/psoriasis/dermwiretv-incytes-opzelura-bms-patient-week-science-of-skincare-summit/20003/Incyte’s Opzelura is the first topical JAK inhibitor approved in the US. Lawrence Eichenfield, MD weighs in on the cream formulation of ruxolitinib for treatment of mild-to-moderate atopic dermatitis in non-immunocompromised patients 12 years of age and older. Bristol Myers Squibb's seventh Global PAtopic Dermatitis Journal Club: AD Guidelines May Represent a ‘Paradigm Shift’ in Care
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/atopic-derm-journal-club-ad-guidelines-may-represent-a-paradigm-shift-in-care/24075/In the first video of this series, Derek Chu, MD and Peter Lio, MD talk about new atopic dermatitis (AD) guidelines from the American Academy of Allergy, Asthma and Immunology Joint Task Force. These guidelines potentially represent a reshaping of the approach to AD care and understanding, accordingRecent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-11/23225/